EYPT
Price
$14.01
Change
+$2.13 (+17.93%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
818.86M
54 days until earnings call
GLUE
Price
$4.92
Change
+$0.01 (+0.20%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
303.24M
62 days until earnings call
Interact to see
Advertisement

EYPT vs GLUE

Header iconEYPT vs GLUE Comparison
Open Charts EYPT vs GLUEBanner chart's image
EyePoint Pharmaceuticals
Price$14.01
Change+$2.13 (+17.93%)
Volume$31.27K
Capitalization818.86M
Monte Rosa Therapeutics
Price$4.92
Change+$0.01 (+0.20%)
Volume$1.64K
Capitalization303.24M
EYPT vs GLUE Comparison Chart in %
Loading...
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLUE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EYPT vs. GLUE commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EYPT is a Buy and GLUE is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (EYPT: $11.88 vs. GLUE: $4.91)
Brand notoriety: EYPT and GLUE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EYPT: 128% vs. GLUE: 65%
Market capitalization -- EYPT: $818.86M vs. GLUE: $303.24M
EYPT [@Biotechnology] is valued at $818.86M. GLUE’s [@Biotechnology] market capitalization is $303.24M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.77B to $0. The average market capitalization across the [@Biotechnology] industry is $1.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EYPT’s FA Score shows that 1 FA rating(s) are green whileGLUE’s FA Score has 0 green FA rating(s).

  • EYPT’s FA Score: 1 green, 4 red.
  • GLUE’s FA Score: 0 green, 5 red.
According to our system of comparison, EYPT is a better buy in the long-term than GLUE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EYPT’s TA Score shows that 4 TA indicator(s) are bullish while GLUE’s TA Score has 5 bullish TA indicator(s).

  • EYPT’s TA Score: 4 bullish, 3 bearish.
  • GLUE’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, EYPT is a better buy in the short-term than GLUE.

Price Growth

EYPT (@Biotechnology) experienced а +2.41% price change this week, while GLUE (@Biotechnology) price change was +1.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.44%. For the same industry, the average monthly price growth was +9.94%, and the average quarterly price growth was +31.78%.

Reported Earning Dates

EYPT is expected to report earnings on Oct 29, 2025.

GLUE is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+2.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EYPT($819M) has a higher market cap than GLUE($303M). EYPT YTD gains are higher at: 59.463 vs. GLUE (-29.251). GLUE has higher annual earnings (EBITDA): 23.3M vs. EYPT (-172.05M). GLUE has more cash in the bank: 291M vs. EYPT (256M). EYPT has less debt than GLUE: EYPT (21.8M) vs GLUE (41.1M). GLUE has higher revenues than EYPT: GLUE (178M) vs EYPT (51.9M).
EYPTGLUEEYPT / GLUE
Capitalization819M303M270%
EBITDA-172.05M23.3M-738%
Gain YTD59.463-29.251-203%
P/E RatioN/A12.59-
Revenue51.9M178M29%
Total Cash256M291M88%
Total Debt21.8M41.1M53%
FUNDAMENTALS RATINGS
EYPT: Fundamental Ratings
EYPT
OUTLOOK RATING
1..100
70
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
PROFIT vs RISK RATING
1..100
82
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
18
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EYPTGLUE
RSI
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
88%
Declines
ODDS (%)
Bearish Trend 8 days ago
88%
Bearish Trend 18 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLUE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CBBZX6.810.06
+0.89%
AB Relative Value Z
IIVAX27.920.22
+0.79%
Transamerica Small/Mid Cap Value A
EMCCX56.940.41
+0.73%
Empiric Class C
BRLGX36.690.23
+0.63%
American Beacon Man Lg Cp Growth R5
FCASX30.12N/A
N/A
Fidelity Advisor Asset Manager 70% C

EYPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, EYPT has been loosely correlated with OCUL. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if EYPT jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EYPT
1D Price
Change %
EYPT100%
-1.00%
OCUL - EYPT
65%
Loosely correlated
-1.85%
LYRA - EYPT
58%
Loosely correlated
-1.95%
ATHE - EYPT
54%
Loosely correlated
N/A
BEAM - EYPT
53%
Loosely correlated
-1.17%
RXRX - EYPT
52%
Loosely correlated
-2.38%
More

GLUE and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLUE has been loosely correlated with EYPT. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if GLUE jumps, then EYPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLUE
1D Price
Change %
GLUE100%
-1.80%
EYPT - GLUE
48%
Loosely correlated
-1.00%
NRIX - GLUE
40%
Loosely correlated
-3.59%
ITRM - GLUE
40%
Loosely correlated
+0.48%
FATE - GLUE
39%
Loosely correlated
-2.71%
IMNM - GLUE
39%
Loosely correlated
-4.39%
More